Locations Main Campus: Chesterfield, MO 63017   |   Locations
314-434-1500 314-434-1500   |   Contact Us

Multimedia Encyclopedia


 
E-mail Form
Email Results

 
 
Print-Friendly
Bookmarks
bookmarks-menu

Felty syndrome

Seropositive rheumatoid arthritis (RA); Felty's syndrome

 

Felty syndrome is a disorder that involves rheumatoid arthritis, a swollen spleen, decreased white blood cell count, and repeated infections. It is rare.

Causes

 

The cause of Felty syndrome is unknown. It is more common in people who have had rheumatoid arthritis (RA) for a long time. People with this syndrome are at risk for infection because they have a low white blood cell count.

 

Symptoms

 

Symptoms include:

  • General feeling of discomfort (malaise)
  • Fatigue
  • Loss of appetite
  • Unintentional weight loss
  • Pale-looking skin
  • Joint swelling, stiffness, pain, and deformity
  • Recurrent infections
  • Eye burning or discharge

 

Exams and Tests

 

A physical exam will show:

  • Swollen spleen
  • Joints that show signs of rheumatoid arthritis
  • Possibly swollen liver and lymph nodes

A complete blood count (CBC) may show a lower number of white blood cells called neutrophils.

An abdominal ultrasound may confirm a swollen spleen.

 

Treatment

 

In most cases, people who have this syndrome are not getting full treatment for rheumatoid arthritis. They may need other medicines to suppress their immune system and reduce the activity of their RA.

Methotrexate may improve the low white blood cell count.

Granulocyte-colony stimulating factor (G-CSF) may raise the neutrophil count.

Some people benefit from removal of the spleen (splenectomy).

 

Outlook (Prognosis)

 

Without treatment, infections may continue to occur.

RA is likely to get worse.

 

Possible Complications

 

You may have infections that keep coming back.

 

When to Contact a Medical Professional

 

Call your health care provider if you develop symptoms of this disorder.

 

Prevention

 

Prompt treatment of RA with currently available medicines decreases the risk of developing Felty syndrome.

 

 

References

Starkebaum G. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease. Curr Opin Hematol. 1997;4(3):196-9. PMID: 9209836 www.ncbi.nlm.nih.gov/pubmed/9209836.

Sweeney SE, Harris ED, Firestein GS. Clinical features of rheumatoid arthritis. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, eds. Kelley's Textbook of Rheumatology. 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 70.

 
  • Antibodies

    Antibodies - illustration

    Antigens are large molecules (usually proteins) on the surface of cells, viruses, fungi, bacteria, and some non-living substances such as toxins, chemicals, drugs, and foreign particles. The immune system recognizes antigens and produces antibodies that destroy substances containing antigens.

    Antibodies

    illustration

    • Antibodies

      Antibodies - illustration

      Antigens are large molecules (usually proteins) on the surface of cells, viruses, fungi, bacteria, and some non-living substances such as toxins, chemicals, drugs, and foreign particles. The immune system recognizes antigens and produces antibodies that destroy substances containing antigens.

      Antibodies

      illustration

    A Closer Look

     

      Talking to your MD

       

        Self Care

         

          Tests for Felty syndrome

           

             

            Review Date: 4/28/2015

            Reviewed By: Gordon A. Starkebaum, MD, Professor of Medicine, Division of Rheumatology, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

            The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
            adam.com

             
             
             

             

             

            A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.



            Content is best viewed in IE9 or above, Firefox and Google Chrome browser.